BACKGROUND: The neurobiology of alcohol dependence (AD) involves alterations in neurotransmitters and the stress response. We hypothesized that an interaction between functional variants of dopaminergic and neurotrophic genes may influence drinking in AD. METHODS: The relationship between alcohol consumption and single-nucleotide polymorphisms, Val66Met in the brain-derived neurotrophic factor (BDNF), and Val158Met in the catechol-O-methyltransferase (COMT), was analyzed among 281 alcohol-dependent individuals. RESULTS: Individuals carrying both the COMT Met158Met genotype and the BDNF Val66Val genotype drank more than those with other variants of these genes (P = 0.039). Those who had a family history of AD also drank more than those without a family history (P = 0.048). Patients with both Met/Met genotype in the COMT Val158Met polymorphism and Val/Val genotype in the BDNF Val66Met polymorphism suffered from more health problems than those carrying other variants (P = 0.030) and had lower motivation to change drinking patterns (P = 0.031). CONCLUSIONS: Patients carrying both the BDNF Val66Val and COMT Met158Met variants had higher alcohol consumption. These effects may be influenced by the effects of BDNF and COMT on dopamine responses to alcohol. Motivation-enhancing strategies might benefit the group of patients identified by genotyping in this study, and also treatment aimed at reducing alcohol consumption.
BACKGROUND: The neurobiology of alcohol dependence (AD) involves alterations in neurotransmitters and the stress response. We hypothesized that an interaction between functional variants of dopaminergic and neurotrophic genes may influence drinking in AD. METHODS: The relationship between alcohol consumption and single-nucleotide polymorphisms, Val66Met in the brain-derived neurotrophic factor (BDNF), and Val158Met in the catechol-O-methyltransferase (COMT), was analyzed among 281 alcohol-dependent individuals. RESULTS: Individuals carrying both the COMTMet158Met genotype and the BDNFVal66Val genotype drank more than those with other variants of these genes (P = 0.039). Those who had a family history of AD also drank more than those without a family history (P = 0.048). Patients with both Met/Met genotype in the COMTVal158Met polymorphism and Val/Val genotype in the BDNF Val66Met polymorphism suffered from more health problems than those carrying other variants (P = 0.030) and had lower motivation to change drinking patterns (P = 0.031). CONCLUSIONS:Patients carrying both the BDNFVal66Val and COMTMet158Met variants had higher alcohol consumption. These effects may be influenced by the effects of BDNF and COMT on dopamine responses to alcohol. Motivation-enhancing strategies might benefit the group of patients identified by genotyping in this study, and also treatment aimed at reducing alcohol consumption.
Authors: Any Carolina C G Vasconcelos; Edmilson de Souza R Neto; Giovanny R Pinto; France Keiko N Yoshioka; Fábio José N Motta; Daniel Fernando P Vasconcelos; Renata Canalle Journal: Alcohol Clin Exp Res Date: 2015-02 Impact factor: 3.455
Authors: Anja Plemenitas; Matej Kastelic; Stefan o Porcelli; Alessandro Serretti; Vita Dolžan; Blanka Kores Plesnicar Journal: Neuropsychobiology Date: 2015 Impact factor: 2.328
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger Journal: Cell Date: 2003-01-24 Impact factor: 41.582
Authors: Yann Ehinger; Khanhky Phamluong; David Darevesky; Melanie Welman; Jeffrey J Moffat; Samuel A Sakhai; Ellanor L Whiteley; Anthony L Berger; Sophie Laguesse; Mehdi Farokhnia; Lorenzo Leggio; Marie Lordkipanidzé; Dorit Ron Journal: Addict Biol Date: 2020-03-05 Impact factor: 4.280
Authors: Damian Czarnecki; Marcin Ziółkowski; Jan Chodkiewicz; Anna Długosz; Joanna Feldheim; Napoleon Waszkiewicz; Agnieszka Kułak-Bejda; Marta Gorzkiewicz; Jacek Budzyński; Anna Junkiert-Czarnecka; Agnieszka Siomek-Górecka; Krzysztof Nicpoń; Aleksandra Kawala-Sterniuk; Raffaele Ferri; Mariusz Pelc; Piotr Walecki; Ewa Laskowska; Edward Jacek Gorzelańczyk Journal: J Clin Med Date: 2021-12-15 Impact factor: 4.241